Shares of Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $15.90 and last traded at $16.00, with a volume of 22944 shares trading hands. The stock had previously closed at $16.08.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a research report on Sunday, November 3rd.
Read Our Latest Research Report on AVNS
Avanos Medical Trading Down 0.3 %
The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The firm has a market cap of $736.69 million, a price-to-earnings ratio of 47.15 and a beta of 0.95. The company has a 50-day moving average price of $19.57 and a 200 day moving average price of $21.29.
Institutional Trading of Avanos Medical
A number of hedge funds have recently made changes to their positions in AVNS. Azzad Asset Management Inc. ADV grew its position in Avanos Medical by 8.5% during the second quarter. Azzad Asset Management Inc. ADV now owns 28,521 shares of the company's stock valued at $568,000 after purchasing an additional 2,223 shares in the last quarter. Natixis Advisors LLC boosted its stake in shares of Avanos Medical by 19.5% during the 2nd quarter. Natixis Advisors LLC now owns 18,878 shares of the company's stock valued at $376,000 after buying an additional 3,077 shares during the period. Paradice Investment Management LLC grew its holdings in shares of Avanos Medical by 5.4% during the 2nd quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company's stock valued at $26,791,000 after acquiring an additional 69,389 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Avanos Medical in the second quarter worth $444,000. Finally, American Century Companies Inc. raised its holdings in shares of Avanos Medical by 12.1% during the second quarter. American Century Companies Inc. now owns 82,930 shares of the company's stock worth $1,652,000 after acquiring an additional 8,929 shares in the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.
About Avanos Medical
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
